Search

everythinglearnresearchcommunity

for

Search:↓

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Genetic differences affect COVID-19 severity and treatment effectiveness.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Most young people in Vladivostok view COVID-19 vaccination positively but value personal freedom and have mixed feelings about restrictions and vaccine safety.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Biologics for severe asthma have known side effects, but some new risks need more study.

COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Some drugs may help treat both COVID-19 and radiation injury.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Researchers found several compounds that could potentially treat Zika virus.

COVID-19 often causes hair loss, especially in women.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A new delivery system makes Curcumin more effective and safer against viruses.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.